Moore Capital Management LP Takes $3.22 Million Position in Danaher Corporation $DHR

Moore Capital Management LP bought a new position in Danaher Corporation (NYSE:DHR) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 16,927 shares of the conglomerate’s stock, valued at approximately $3,224,000.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Meeder Asset Management Inc. acquired a new stake in shares of Danaher during the 2nd quarter valued at $44,000. MidFirst Bank purchased a new position in Danaher in the second quarter valued at about $46,000. Bell Investment Advisors Inc acquired a new position in Danaher in the 2nd quarter worth about $47,000. Fiduciary Financial Advisors acquired a new position in Danaher in the second quarter worth approximately $53,000. Finally, Solstein Capital LLC bought a new position in Danaher during the second quarter valued at approximately $58,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have commented on the stock. Guggenheim lowered their target price on shares of Danaher from $235.00 to $200.00 and set a “buy” rating on the stock in a research report on Wednesday, July 22nd. Piper Sandler assumed coverage on Danaher in a research note on Thursday, June 11th. They issued a “neutral” rating and a $200.00 price objective on the stock. HSBC reduced their target price on Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a report on Wednesday, June 3rd. Evercore reissued an “outperform” rating and issued a $230.00 price target on shares of Danaher in a research report on Monday, July 6th. Finally, Stifel Nicolaus reduced their price objective on shares of Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $228.91.

Danaher Price Performance

Shares of Danaher stock opened at $213.90 on Tuesday. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The firm’s 50-day simple moving average is $200.18 and its 200-day simple moving average is $192.31. The firm has a market cap of $150.37 billion, a P/E ratio of 37.99, a price-to-earnings-growth ratio of 2.69 and a beta of 0.78.

Danaher (NYSE:DHR) last released its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. The firm had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The company’s revenue for the quarter was up 5.5% compared to the same quarter last year. During the same period in the previous year, the business earned $0.77 earnings per share. As a group, research analysts expect that Danaher Corporation will post 8.53 EPS for the current fiscal year.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.